We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy
Dynamin Inhibitory Peptide is a peptide inhibitor of the GTPase dynamin, which competitively blocks binding of dynamin to amphiphysin, thus it prevents endocytosis when administered intracellularly. It lead to GABAA receptor internalization reduce and miniature ISPC amplitude and frequency in neurons expressing GABAA receptors increase.
CAT No: R0850
CAS No: 251634-21-6
Synonyms/Alias: Dynamin inhibitory peptide;251634-21-6;L-Proline, L-glutaminyl-L-valyl-L-prolyl-L-seryl-L-arginyl-L-prolyl-L-asparaginyl-L-arginyl-L-alanyl-;QVPSRPNRAP;HY-P1083;AKOS024456770;DA-63063;MS-31983;CS-0027626;G13347;
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C47H80N18O14 |
M.W/Mr. | 1121.3 |
Sequence | One Letter Code:QVPSRPNRAP Three Letter Code:H-Gln-Val-Pro-Ser-Arg-Pro-Asn-Arg-Ala-Pro-OH |
Labeling Target | GTPase dynamin |
Purity | >98 % |
Activity | Inhibitor |
Long-term Storage Conditions | Soluble in DMSO |
Solubility | -20 °C |
InChI | InChI=1S/C47H80N18O14/c1-23(2)35(62-36(69)25(48)14-15-33(49)67)44(77)64-19-7-12-31(64)41(74)61-29(22-66)39(72)59-27(10-5-17-56-47(53)54)43(76)63-18-6-11-30(63)40(73)60-28(21-34(50)68)38(71)58-26(9-4-16-55-46(51)52)37(70)57-24(3)42(75)65-20-8-13-32(65)45(78)79/h23-32,35,66H,4-22,48H2,1-3H3,(H2,49,67)(H2,50,68)(H,57,70)(H,58,71)(H,59,72)(H,60,73)(H,61,74)(H,62,69)(H,78,79)(H4,51,52,55)(H4,53,54,56)/t24-,25-,26-,27-,28-,29-,30-,31-,32-,35-/m0/s1 |
InChI Key | LHQOQXYEPUSHJL-LNIRUYPRSA-N |
Isomeric SMILES | C[C@@H](C(=O)N1CCC[C@H]1C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)N)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CO)NC(=O)[C@@H]3CCCN3C(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(=O)N)N |
BoilingPoint | N/A |
Melting Point | N/A |
1. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
2. TMEM16F and dynamins control expansive plasma membrane reservoirs
3. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
4. Emu oil in combination with other active ingredients for treating skin imperfections
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.